Skip to main content
Article thumbnail
Location of Repository

Screening of Crude Plant Extracts with Anti-Obesity Activity

By Changhyun Roh and Uhee Jung


Obesity is a global health problem. It is also known to be a risk factor for the development of metabolic disorders, type 2 diabetes, systemic hypertension, cardiovascular disease, dyslipidemia, and atherosclerosis. In this study, we screened crude extracts from 400 plants to test their anti-obesity activity using porcine pancreatic lipase assay (PPL; triacylglycerol lipase, EC in vitro activity. Among the 400 plants species examined, 44 extracts from plants, showed high anti-lipase activity using 2,4-dinitrophenylbutyrate as a substrate in porcine pancreatic lipase assay. Furthermore, 44 plant extracts were investigated for their inhibition of lipid accumulation in 3T3-L1 cells. Among these 44 extracts examined, crude extracts from 4 natural plant species were active. Salicis Radicis Cortex had the highest fat inhibitory activity, whereas Rubi Fructus, Corni Fructus, and Geranium nepalense exhibited fat inhibitory capacity higher than 30% at 100 μg/mL in 3T3-L1 adipocytes, suggesting anti-obesity activity. These results suggest that four potent plant extracts might be of therapeutic interest with respect to the treatment of obesity

Topics: Article
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1983). A peroxidase-coupled method for the colorimetric determination of serum triglycerides.
  2. (2009). Adipose tissue engineering: State of the art, recent advances and innovative approaches. Expert Rev. Med. Devices
  3. (2008). Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes.
  4. (2010). Anti-obesity effect of Morus bombycis root extract: Anti-lipase activity and lipolytic
  5. (2003). Compendium of Materia Medica; Foreign Languages Press:
  6. (2004). Dietary fat composition and the metabolic syndrome.
  7. (2001). Effects of plant sterols and stanols on lipid metabolism and cardiovascular risk.
  8. (2009). Fatty acid metabolism: Target for metabolic syndrome.
  9. (2009). Foods fortified with phytosterins: Their role in decreasing serum cholesterol level, their European Community authorization and requirements for placing them on the market.
  10. High-throughput screening for small-molecule adiponectin secretion modulators.
  11. (2012). Indigenous use and bio-efficacy of medicinal plants in the Rasuwa District, Central Nepal.
  12. (1997). Inhibition of lipid absorption as an approach to the treatment of obesity.
  13. Inhibitory activities of Rubi fructus on digestive enzymes.
  14. Lipid metabolism enzymes: Emerging drug targets for the treatment of obesity.
  15. (2000). Medicinal strategies in the treatment of obesity.
  16. (2008). Natural polyphenols as proteasome modulators and their role as anti-cancer compounds.
  17. (2001). Obesity and the regulation of energy balance. Cell
  18. (2000). Obesity as a medical problem.
  19. (1989). p-Nitrophenyl butyrate hydrolyzing activity of hormone-sensitive lipase from bovine adipose tissue.
  20. (2009). Potential of flavonoids as antiinflammatory agents: Modulation of pro-inflammatory gene expression and signal transduction pathways. Curr. Drug Metab.
  21. (2008). PPARδ as a therapeutic target in metabolic disease. FEBS Lett.
  22. (2009). Protection against hypercholesterolemia by Corni fructus extract and its related protective mechanism.
  23. Screening of anti-lipase properties of 37 traditional Chinese medicinal herbs.
  24. (2005). Screening of some medicinal plants for anti-lipase activity.
  25. SPARC: A key player in the pathologies associated with obesity and diabetes.
  26. (2007). Suppression of free-radicals and protection against H2O2-induced oxidative damage in HPF-1 cell by oxidized phenolic compounds present in black tea. Food Chem.
  27. (2004). Taraxasterol and beta-sitosterol: New naturally compounds with chemoprotective/chemopreventive effects. Neoplasma
  28. (2005). Up-regulation of adipogenin, an adipocyte plasma transmembrane protein, during adipogenesis.
  29. (2010). version 19.0; IBM:
  30. (2008). White adipose tissue as endocrine organ and its role in obesity.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.